HEVC Advance
Founded Year
2015About HEVC Advance
HEVC Advance is an independent licensing administrator company formed to lead the development, administration and management of a new HEVC/H.265 Patent Pool for licensing HEVC/H.265 essential patents. HEVC Advance will provide a transparent and efficient licensing mechanism for HEVC/H.265 essential patented technology.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Latest HEVC Advance News
Feb 13, 2023
“We are very pleased that Sharp, Motorola Mobility, and Kyocera have become Licensees of the HEVC Advance Patent Pool. All three companies are leaders in the consumer electronics marketplace, and their participation in the HEVC Advance Patent Pool is another indicator of the value the HEVC Advance pool provides.” Sharp Corporation, Motorola Mobility LLC, and Kyocera Corporation, among other recent additions, have become Licensees of the HEVC Advance Patent Pool. The HEVC Advance Patent Pool license now includes over 20,500 HEVC/H.265 essential patents issued in 116 countries, of which over 17,650 are exclusively available for a pool license through HEVC Advance. According to Access Advance CEO, Peter Moller, “We are very pleased that Sharp, Motorola Mobility, and Kyocera have become Licensees of the HEVC Advance Patent Pool. All three companies are leaders in the consumer electronics marketplace, and their participation in the HEVC Advance Patent Pool is another indicator of the value the HEVC Advance pool provides.” Related Posts Feb 13, 2023 “We are also extremely proud to now have 40 Licensors in our program, with collectively over 20,500 patents. Our successful and continuing efforts to consolidate over 75% of the HEVC/H.265 patent landscape provides unmatched and unprecedented value to both our licensors and licensees. Moreover, 31 of those licensors, accounting for 85% (over 17,650) of the pool’s patents, are now granting pool licenses to their HEVC essential patents exclusively through the HEVC Advance Patent Pool. We commend these licensors for their efforts to bring greater simplicity to the marketplace.” Access Advance LLC is an independent licensing administrator company formed to lead the development, administration, and management of patent pools for licensing essential patents of the most important standards-based video codec technologies. Access Advance provides a transparent and efficient licensing mechanism for both patent owners and patent implementers. Access Advance currently manages and administers the HEVC Advance Patent Pool for licensing patents essential to H.265/HEVC technology, and the separate and independent VVC Advance Patent Pool for licensing essential patents to VVC/H.266 technology. The HEVC Advance Patent Pool and the VVC Advance Patent Pool are elements of the Access Advance Video Codec Platform Initiative that seamlessly incorporates HEVC and VVC technologies into a single discounted royalty rate structure through the Multi-Codec Bridging Agreement for eligible Licensees whose products include both HEVC and VVC codecs. This innovation responds to the market’s desire for an even more efficient next-generation pool licensing structure.
HEVC Advance Frequently Asked Questions (FAQ)
When was HEVC Advance founded?
HEVC Advance was founded in 2015.
Where is HEVC Advance's headquarters?
HEVC Advance's headquarters is located at 28 State St., Boston.
Who are HEVC Advance's competitors?
Competitors of HEVC Advance include PatentSight and 4 more.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Compare HEVC Advance to Competitors
Quartzy offers a cloud-based platform for laboratory management. It offers lab management solutions for small and medium-sized research and development organizations to manage their inventory, streamline purchasing communications, and consolidate orders. It was founded in 2009 and is based in Hayward, California.
Glycologic Limited is a company dedicated to the creation of nutritional, clinical nutrition and drug delivery systems based on carbohydrates which overcome the limitations of other technologies. The Company utilises the properties of carbohydrates to develop customised solutions to a wide variety of nutritional and pharmaceutical problems.
Tandem is a medical device company located in San Diego. The company manufactures and sells an automated drug delivery system primarily for use in home-administered IV's. The device is a relatively simple mechanical pump that is simpler and safer to use than standard IV therapy.
Informed Medical is an interactive medical information services provider that enables biopharmaceutical companies to market directly to physicians and patients.
Laureate Pharma, Inc. is a full service contract manufacturing organization(CMO) providing development and cGMP manufacturing services in the company's FDA registered facilities in Princeton, New Jersey. The company is dedicated to supporting the development and commercialization of biopharmaceutical, drug and diagnostic products for pharmaceutical, diagnostic and biotech companies.The company aims to provide a range of product development and manufacturing services from cell line optimization and process design to development of full-scale cGMP protein production, purification and aseptic filling, in addition to corresponding testing, validation, analytical and regulatory support. The company's focus is on mammalian cell based monoclonal antibody and recombinant protein production for clinical and modest commercial supply.The company view the company's customers as partners and provide them with flexible solutions that reduce time to clinic and market. Focused on operational excellence, the company's highly experienced staff works with the company's customers to improve the quality of their products and processes.The company value the company's customers, stakeholders and associates. Therefore, the company measure the company's success by meeting the company's customers' needs, generating results in terms of quality, timeliness and on budget performance, as well as fostering an environment of trust, growth and diversity for the company's team.
utilized "combinatorial chemistry" technology to discover lead therapeutic and diagnostic compounds.�MACUGEN, approved for wet age-related macular degeneration, was discovered using this technology. Upon NeXagen's merger with Vestar, Inc., the company also marketed and developed liposomal drug delivery products.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
